Top Dallas, TX Biotech Startups (18)

Our mission is to increase conservation and conservation awareness by developing microclimate-controlled devices for plants. Through our work, we increase the total amount of livable space available to plants and animals.

Refocus Group is a medical device company engaged in the research and development of treatments for human vision disorders.

BioPharma research company with ground breaking treatment for Therapy Resistant Metastatic Breast Cancer.

Precision Biologics is a Biotechnology company located in 5910 N Central Expy, Dallas, Texas, United States.

Instil Bio is a biotechnology company that develops cell therapies for solid tumor cures.

Almaden Genomics is accelerating genomic discovery with g.nome, a cloud-native platform designed to streamline genomic workflows. Brought to market by a team of bioinformaticians, engineers and industry professionals, Almaden’s g.nome platform allows for a low-code/no-code pipeline build. With a visual drag-and-drop pipeline builder that utilizes toolkits and pre-built workflows from a curated library, g.nome is giving power to researchers —...

Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine,...

Scout Clinical’s mission is to make it easier for patients to participate in clinical trials. From travel arrangements and payment management to regulatory review and special services, we do it all.

SCBT is a leading producer of monoclonal antibodies, RNAi, CRISPR KO/Activation products and chemicals for research. Cited in over 360,693 publications.

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species...

Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we hope to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive,...

Caddo Medical Technologies is dedicated to innovation in pulmonary medicine, with a simple mission — to help people breath better. Caddo develops and patents creative solutions in the global respiratory arena.

We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.

Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability...

Mentrik Biotech, LLC is a private biopharmaceutical company that was incorporated in December 2010 and is headquartered in Dallas, TX. The goal of Mentrik Biotech is to optimize oncology-based therapeutics to treat patients with significant unmet medical need.

Dialectic Therapeutics is a biotechnology company which is created for innovative technologies to cure cancer.

Founded in 2018, Sandhill Therapeutics has harnessed the power of Natural Killer (NK) cells and innate T cell populations to maximize tumor killing and to provide a cost-effective, universal, cellular immuno-oncology therapy.

ImmuneSensor Therapeutics is a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system. Based on groundbreaking discoveries from the research of the 2019 Breakthrough Prize awardee, Dr. Zhijian “James” Chen, we are pioneering a differentiated approach to both STING activators to boost anticancer immunity and cGAS inhibitors to suppress autoimmunity...